Compare NATR & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATR | CLPT |
|---|---|---|
| Founded | 1972 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.7M | 353.5M |
| IPO Year | 1995 | 2009 |
| Metric | NATR | CLPT |
|---|---|---|
| Price | $20.65 | $13.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $28.33 | $20.00 |
| AVG Volume (30 Days) | 113.8K | ★ 545.4K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $480,144,000.00 | $36,971,000.00 |
| Revenue This Year | $7.76 | $45.67 |
| Revenue Next Year | $4.82 | $19.51 |
| P/E Ratio | $70.34 | ★ N/A |
| Revenue Growth | 5.67 | ★ 17.78 |
| 52 Week Low | $12.97 | $8.27 |
| 52 Week High | $28.14 | $30.10 |
| Indicator | NATR | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 54.84 |
| Support Level | $19.38 | $12.87 |
| Resistance Level | $21.55 | $13.59 |
| Average True Range (ATR) | 0.74 | 1.02 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 37.52 | 48.45 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.